Shares of Aflac Incorporated (NYSE:AFL – Get Free Report) have been given an average rating of “Hold” by the fifteen ratings firms that are presently covering the company, Marketbeat Ratings reports. Three analysts have rated the stock with a sell rating, nine have issued a hold rating and three have assigned a buy rating to the company. The average 1-year price target among brokerages that have issued a report on the stock in the last year is $98.73.
A number of analysts have weighed in on AFL shares. Barclays initiated coverage on shares of Aflac in a report on Wednesday, September 4th. They set an “underweight” rating and a $96.00 target price on the stock. Piper Sandler lifted their target price on Aflac from $114.00 to $122.00 and gave the company an “overweight” rating in a research note on Wednesday, October 2nd. Truist Financial increased their price target on Aflac from $100.00 to $105.00 and gave the stock a “hold” rating in a research report on Friday, November 1st. Bank of America boosted their price objective on Aflac from $115.00 to $124.00 and gave the company a “buy” rating in a research report on Thursday, October 10th. Finally, Wells Fargo & Company increased their target price on Aflac to $107.00 and gave the stock a “hold” rating in a research report on Tuesday, December 3rd.
Read Our Latest Research Report on AFL
Institutional Investors Weigh In On Aflac
Aflac Stock Performance
Shares of AFL stock opened at $104.52 on Friday. The company has a debt-to-equity ratio of 0.32, a quick ratio of 0.08 and a current ratio of 0.08. The stock has a market capitalization of $58.06 billion, a price-to-earnings ratio of 15.74, a PEG ratio of 2.09 and a beta of 0.97. Aflac has a one year low of $75.07 and a one year high of $115.50. The company’s 50-day simple moving average is $110.14 and its 200-day simple moving average is $102.73.
Aflac (NYSE:AFL – Get Free Report) last released its earnings results on Wednesday, October 30th. The financial services provider reported $2.16 EPS for the quarter, topping analysts’ consensus estimates of $1.69 by $0.47. The company had revenue of $2.95 billion for the quarter, compared to the consensus estimate of $4.30 billion. Aflac had a return on equity of 16.34% and a net margin of 22.02%. Aflac’s quarterly revenue was down 40.4% compared to the same quarter last year. During the same quarter last year, the business posted $1.84 EPS. Equities analysts anticipate that Aflac will post 7.27 earnings per share for the current fiscal year.
Aflac Increases Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Monday, March 3rd. Stockholders of record on Wednesday, February 19th will be issued a $0.58 dividend. The ex-dividend date is Wednesday, February 19th. This is a boost from Aflac’s previous quarterly dividend of $0.50. This represents a $2.32 annualized dividend and a dividend yield of 2.22%. Aflac’s dividend payout ratio (DPR) is 30.12%.
Aflac Company Profile
Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.
Read More
- Five stocks we like better than Aflac
- What is the FTSE 100 index?
- FinWise Bancorp’s CEO Talks Strategy Behind Fintech Success
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- Broadcom: Turning the Mag 7 Into 8 Trillion-Dollar Tech Giants
- Russell 2000 Index, How Investors Use it For Profitable Trading
- SoundHound AI: Can Its Meteoric Rise Sustain Into 2025?
Receive News & Ratings for Aflac Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aflac and related companies with MarketBeat.com's FREE daily email newsletter.